Free Trial
OTCMKTS:VYNT

Vyant Bio (VYNT) Stock Price, News & Analysis

Vyant Bio logo
$0.19 +0.01 (+7.78%)
As of 12/29/2023

About Vyant Bio Stock (OTCMKTS:VYNT)

Key Stats

Today's Range
$0.18
$0.20
50-Day Range
$0.19
$0.19
52-Week Range
$0.14
$1.58
Volume
19,100 shs
Average Volume
161,822 shs
Market Capitalization
$1.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vyant Bio and its competitors with MarketBeat's FREE daily newsletter.

VYNT Stock News Headlines

Vyant Bio Inc VYNT
Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
Vyant Bio, Inc.: Vyant Bio Provides Update on Winddown Activities
Vyant Bio Provides Update on Winddown Activities
See More Headlines

VYNT Stock Analysis - Frequently Asked Questions

Vyant Bio's stock was trading at $0.1940 on January 1st, 2025. Since then, VYNT stock has increased by 0.0% and is now trading at $0.1940.

Vyant Bio, Inc. (OTCMKTS:VYNT) released its quarterly earnings results on Thursday, November, 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.75). The business earned $1.51 million during the quarter, compared to the consensus estimate of $2.19 million. Vyant Bio had a negative net margin of 3,474.81% and a negative trailing twelve-month return on equity of 151.82%.
Read the conference call transcript
.

Shares of Vyant Bio reverse split on Wednesday, November 2nd 2022.The 1-5 reverse split was announced on Wednesday, November 2nd 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, November 2nd 2022. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of VYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vyant Bio investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), Alphabet (GOOG) and JPMorgan Chase & Co. (JPM).

Company Calendar

Last Earnings
11/11/2021
Today
8/10/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:VYNT
CIK
1349929
Employees
30
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$22.69 million
Net Margins
-3,474.81%
Pretax Margin
-3,281.86%
Return on Equity
-151.82%
Return on Assets
-97.14%

Debt

Debt-to-Equity Ratio
0.04
Current Ratio
2.86
Quick Ratio
2.86

Sales & Book Value

Annual Sales
$670 thousand
Price / Sales
1.83
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.69 per share
Price / Book
0.11

Miscellaneous

Outstanding Shares
6,330,000
Free Float
5,724,000
Market Cap
$1.23 million
Optionable
Not Optionable
Beta
1.73
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:VYNT) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners